CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
159 hedge funds and large institutions have $337M invested in Clovis Oncology, Inc. in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 68 increasing their positions, 30 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
14% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 28
16% less call options, than puts
Call options by funds: $21.8M | Put options by funds: $26M
Holders
159
Holding in Top 10
1
Calls
$21.8M
Puts
$26M
Top Buyers
| 1 | +$13.4M | |
| 2 | +$5.84M | |
| 3 | +$3.24M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.64M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$1.99M |
Top Sellers
| 1 | -$2.46M | |
| 2 | -$1.47M | |
| 3 | -$1.18M | |
| 4 |
Goldman Sachs
New York
|
-$1.02M |
| 5 |
SC
Sculptor Capital
New York
|
-$925K |